BUL/SFA (BUL/SFA)

Bulgarian Stock Exchange: BUL/SFA · EUR

€3.28

+0.01 (+0.3%)· Recorded snapshot

Market cap	1.8B
Revenue (ttm)	1.5B
Net income (ttm)	85M
EPS (ttm)	€0.23
Shares out	538.4M
P/E (trailing)	14.4x
Dividend	€0.14 (4.27%)
Volume	39,789
Beta	0.14

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.5B
Net income (ttm): 85M
EPS (ttm): €0.23
P/E (trailing): 14.4x
Market cap: 1.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E14.4

P25 n/aP50 n/aP75 n/a

ROE17.2

P25 n/aP50 n/aP75 n/a

ROIC9.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BUL/SFA indicators

Market & fundamental data

Available fields

242

Groups with data

Currency

EUR

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Bulgaria
Country code	BG
Earnings date	2026-10-30
Employees	6,049
Employees change	-50
Employees growth	-0.82%
Enterprise value	EUR 2B
Exchange	Bulgarian Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1933
Industry	Pharmaceutical Preparations
Is primary listing	Yes
ISIN number	BG11SOSOBT18
Last earnings date	2026-08-31
Last refreshed	2026-10-29
Last stock split date	2025-07-10
Last stock split type	Forward
Market cap	EUR 1.8B
Next earnings date	2026-10-30
Price	EUR 3.28
Price currency	EUR
SIC code	2834
Stock price date	2026-10-28
Symbol	bul/SFA
Website	https://www.sopharmagroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	10.34x
Average P/E ratio (3Y)	11.46x
Average P/E ratio (5Y)	9.57x
Earnings yield	6.94%
EV/Earnings	24.05x
EV/EBIT	20.16x
EV/EBITDA	14.34x
EV/FCF	57.14x
EV/Sales	1.41x
FCF / EV yield	1.75%
FCF yield	2.03%
Graham number	2.2594
Graham upside	-31.12%
Lynch fair value	EUR 5.69
Lynch upside	73.46%
P/B ratio	3.19x
P/E ratio	14.41x
P/FCF ratio	49.33x
P/OCF ratio	29.01x
P/S ratio	1.22x
Price / tangible book value	4.33x
Price/EBITDA ratio	15.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	5.74%
EBITDA margin	7.94%
Effective tax rate	9.34%
FCF margin	2.46%
Gross margin	24.62%
Operating margin	5.74%
Pretax margin	6.71%
Profit margin	5.85%
Profit per employee	EUR 14,059
Revenue per employee	EUR 240,229
ROA	4.98%
ROA (5Y)	3.81%
ROCE	12.23%
ROE	17.2%
ROE (5Y)	13.05%
ROIC	9.27%
ROIC (5Y)	7.46%
Tax / revenue	0.63%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	121.84%
EPS growth (Q)	-1.34%
EPS growth (QoQ)	-49.73%
EPS growth 10Y	23.64%
EPS growth 3Y	22.71%
EPS growth 5Y	31.78%
FCF growth (QoQ)	-72.7%
FCF growth 3Y	11.39%
Gross profit growth	31.87%
Gross profit growth (Q)	18.4%
Gross profit growth 3Y	20.22%
Gross profit growth 5Y	16.05%
Net income growth	64.91%
Net income growth (Q)	24.5%
Net income growth (QoQ)	-39.63%
Net income growth 3Y	22.19%
Net income growth 5Y	32.08%
OCF growth	272.7%
OCF growth (QoQ)	-46.04%
OCF growth 10Y	18.67%
OCF growth 3Y	15.47%
Operating income growth	64.05%
Operating income growth (Q)	41.18%
Operating income growth 3Y	15.22%
Operating income growth 5Y	26.42%
Revenue growth	17.4%
Revenue growth (Q)	13.12%
Revenue growth (QoQ)	3.62%
Revenue growth 10Y	12.64%
Revenue growth 3Y	16.75%
Revenue growth 5Y	13.23%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -25.1M
Depreciation and amortization	EUR 32M
EBIT	EUR 83.4M
EBITDA	EUR 115.3M
EPS	EUR 0.23
FCF per share	EUR 0.07
Financing cash flow	EUR -34.8M
Free cash flow	EUR 35.8M
Gross profit	EUR 357.8M
Income taxes	EUR 9.1M
Investing cash flow	EUR -18.7M
Net borrowing	EUR -50.3M
Net cash flow	EUR 7.4M
Net income	EUR 85M
Operating income	EUR 83.4M
Revenue	EUR 1.5B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.04
Book value per share	EUR 1.00
Debt / EBITDA	2.3
Debt / equity	0.52
Debt / FCF	8
Goodwill	EUR 2.8M
Interest coverage	7.28
Long-term assets	EUR 510.1M
Long-term liabilities	EUR 127.6M
Net cash (debt)	EUR -261.9M
Net cash / market cap	-14.83%
Net debt / EBITDA	2.27
Net debt / equity	0.47
Net debt / FCF	7.32
Piotroski F-Score	6
Property, plant and equipment	EUR 210.9M
Shareholders' equity	EUR 554.1M
Tangible book value	EUR 408.1M
Tangible book value per share	EUR 0.76
Total assets	EUR 1.1B
Total cash	EUR 24.5M
Total debt	EUR 286.5M
Total liabilities	EUR 527M
WACC	4.8%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.39
Current assets	EUR 571M
Current liabilities	EUR 399.4M
Current ratio	1.43
Inventory turnover	4.39
Net working capital	EUR 318.2M
Quick ratio	0.74
Working capital	EUR 171.6M
Working capital turnover	10.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	25.97%
Dividend growth	80.7%
Dividend growth (10Y)	23.38%
Dividend growth (3Y)	-1.74%
Dividend growth (5Y)	38.93%
Dividend growth years	1
Dividend payment date	2026-08-24
Dividend payment years	4
Dividend payout frequency	Semi-Annual
Dividend per share	EUR 0.14
Dividend yield	4.27%
Ex-dividend date	2026-07-09
FCF payout ratio	145.9%
Last dividend	EUR 0.05
Payout ratio	35.71%
Shareholder yield	30.24%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	559.16%
10Y return CAGR	26.29%
10Y total return	931.82%
150-day SMA	EUR 2.09
15Y price change	489.82%
15Y return CAGR	16.73%
15Y total return	917.7%
1D price change	0.31%
1M price change	27.13%
1M total return	27.13%
1W price change	6.49%
1W total return	6.49%
1Y price change	137.51%
1Y return CAGR	151.97%
1Y total return	151.81%
20-day SMA	EUR 2.86
200-day SMA	EUR 2.03
3M price change	72.63%
3M total return	72.63%
3Y price change	167.97%
3Y return CAGR	50.09%
3Y total return	238.17%
50-day SMA	EUR 2.56
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 3.37
52-week high date	2026-10-23
52-week low	EUR 1.34
52-week low date	2025-11-17
5Y price change	376.26%
5Y return CAGR	46.15%
5Y total return	566.53%
6M price change	89.6%
6M total return	94.85%
All-time high	EUR 3.37
All-time high date	2026-10-23
All-time low	EUR 0.30
All-time low date	2009-02-12
Average true range (ATR)	EUR 0.09
Average volume	40K
Beta (1Y)	0.12
Beta (2Y)	0.04
Beta (5Y)	0.14
Change from 52-week high	-2.67%
Change from 52-week low	144.78%
Change from all-time high	-2.67%
Change from all-time low	1,001.41%
Change from open	0.31%
Day's gap	0%
Dollar volume	EUR 130,508
High price	EUR 3.29
Low price	EUR 3.24
Monthly RSI	93.23
Open price	EUR 3.27
Position in 52-week range	80%
Previous close	EUR 3.27
Price vs 150-day SMA	56.79%
Price vs 20-day SMA	14.57%
Price vs 200-day SMA	61.34%
Price vs 50-day SMA	28.02%
Relative volume	0.99
RSI	83.07
Sharpe ratio	3.18
Sharpe ratio (3Y)	1.78
Sharpe ratio (5Y)	1.68
Sortino ratio	7.71
Sortino ratio (3Y)	3.75
Sortino ratio (5Y)	3.32
Volume	39.8K
Weekly RSI	89.07
YTD price change	130.18%
YTD total return	136.62%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	178.2M
Shares change (QoQ)	1.05%
Shares change (YoY)	-25.97%
Shares held by insiders	9.85%
Shares held by institutions	0.28%
Shares outstanding	538.4M

Deeper analysis on BUL/SFA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BUL/SFA report

Is a complete BUL/SFA research report available?

No complete published report is available for bul/SFA (BUL/SFA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BUL/SFA (BUL/SFA)

Price

Financial snapshot

Fair-value bridge

Latest news · BUL/SFA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BUL/SFA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BUL/SFA

Frequently asked questions